Ethosuximide, valproic acid, and lamotrigine in childhood absence epilepsy: Initial monotherapy outcomes at 12 months

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Epilepsia

• Publication date

  2013-01-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/epi.12028PMID 23167925PMCID PMC3538883
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Developmental Test of Visual-Motor Integration

  2012cited by this paper
• Impaired attention and network connectivity in childhood absence epilepsy

  2011cited by this paper
• Wide Range Assessment of Memory and Learning

  2011cited by this paper
• Wide Range Assessment of Memory and Learning Second Edition TM Screening Report

  2010cited by this paper
• Ethosuximide, valproic acid, and lamotrigine in childhood absence epilepsy.

  2010influential reference
• Wide‐Range Achievement Test

  2010cited by this paper
• Differentiation of attention-related problems in childhood absence epilepsy.

  2010cited by this paper
• Peabody Picture Vocabulary Test

  2010cited by this paper
• Long-term outcome of childhood absence epilepsy: Dutch Study of Epilepsy in Childhood.

  2009cited by this paper
• Woodcock-Johnson III Tests of Achievement.

  2009cited by this paper
• NEPSY: A Developmental Neuropsychological Assessment

  2008cited by this paper
• Woodcock‐Johnson III Tests of Achievement

  2008cited by this paper
• Childhood absence epilepsy: Behavioral, cognitive, and linguistic comorbidities

  2008cited by this paper
• Monitoring Gene Changes during Antiepileptic Drug Therapy to Widen the Safety Window and Reduce Pharmacoresistance

  2007cited by this paper
• ILAE Treatment Guidelines: Evidence‐based Analysis of Antiepileptic Drug Efficacy and Effectiveness as Initial Monotherapy for Epileptic Seizures and Syndromes

  2006influential reference
• Childhood Absence Epilepsy: Evolution and Prognostic Factors

  2005cited by this paper
• Long-term prognosis for childhood and juvenile absence epilepsy

  2004cited by this paper
• Test of Nonverbal Intelligence

  2003cited by this paper
• Data and Safety Monitoring Boards

  2002cited by this paper
• Neuropsychological assessment in children with absence epilepsy

  2001cited by this paper
• Activate your online subscription

  2001cited by this paper
• Bodyweight Gain and Anticonvulsants

  2001cited by this paper
• Prognostic Significance of Failure of the Initial Antiepileptic Drug in Children with Absence Epilepsy

  2001cited by this paper
• Clinical Research : Newly Diagnosed Unprovoked Epileptic Seizures : Presentation at Diagnosis in CAROLE Study

  2001cited by this paper
• How Well Can Epilepsy Syndromes Be Identified at Diagnosis? A Reassessment 2 Years After Initial Diagnosis

  2000cited by this paper
• Validation of a New Quality of Life Measure for Children with Epilepsy

  2000cited by this paper
• Lamictal (Lamotrigine) Monotherapy for Typical Absence Seizures in Children

  1999cited by this paper
• Risk of Excessive Weight Gain in Epileptic Children Treated with Valproate

  1999cited by this paper
• Newly Diagnosed Epilepsy in Children: Presentation at Diagnosis

  1999influential reference
• Weight gain with valproate or carbamazepine--a reappraisal.

  1997cited by this paper
• Long-term psychosocial outcome in typical absence epilepsy. Sometimes a wolf in sheeps' clothing.

  1997cited by this paper
• Will a Critical Level of Hyperventilation‐Induced Hypocapnia Always Induce an Absence Seizure?

  1996cited by this paper
• The outcome of absence epilepsy

  1996cited by this paper
• Classification of epilepsies and epileptic syndromes using the 1989 International League against epilepsy classification: A hospital-based study of 1,250 patients in a developing country

  1995cited by this paper
• Altered Responsiveness During Hyperventilation‐Induced EEG Slowing: A Non‐Epileptic Phenomenon in Normal Children

  1994cited by this paper
• Wisconsin Card Sorting Test Manual – Revised and Expanded

  1993cited by this paper
• Wisconsin Card Sorting Test manual

  1993cited by this paper
• Reaction time, attention, and impulsivity in epilepsy.

  1992cited by this paper
• Pseudoseizures Caused by Hyperventilation Resembling Absence Epilepsy

  1990cited by this paper
• Proposal for Revised Classification of Epilepsies and Epileptic Syndromes

  1989cited by this paper
• Proposal for revised classification of epilepsies and epileptic syndromes. Commission on Classification and Terminology of the International League Against Epilepsy.

  1989cited by this paper
• Absence seizures in children: Clinical and electroencephalographic features

  1987cited by this paper
• Intractable Epilepsy

  1987cited by this paper
• Longterm follow-up of childhood epilepsy with absences. I. Epilepsy with absences at onset.

  1985cited by this paper
• Long‐term prognosis in two forms of childhood epilepsy: Typical absence seizures and epilepsy with rolandic (centrotemporal) EEG foci

  1983cited by this paper
• Clinical and EEG estimates of absence seizure frequency.

  1983cited by this paper
• Effects of sodium valproate in 100 children with special reference to weight.

  1981cited by this paper
• A Study of Children with Epilepsy Attending Ordinary Schools. I: Their Seizure Patterns, Progress and Behaviour in School

  1974cited by this paper
• Long-term follow-up of patients with petit mal.

  1967cited by this paper
• Petit mal epilepsy. Results of a prolonged follow-up study of 117 patients.

  1965cited by this paper
• Prognosis of “pure” petit mal

  1963cited by this paper

• Sustained inhibitory dysfunction in complement component C1qa-deficient mice underlies epilepsy and comorbidities.

  2026cites this paper
• Foundational Work in Absence Epilepsy: Laying the Groundwork and Establishing the Gold-Standard.

  2026cites this paper
• Update on Antiseizure Medications 2025

  2025cites this paper
• Scientific and practical conference “Absence epilepsy”

  2025cites this paper
• Dysregulation of the Cannabinoid System in Childhood Epilepsy: From Mechanisms to Therapy

  2025cites this paper
• Real-world disproportionality analysis of sleep disturbances associated with antiseizure medications in epilepsy: a pharmacovigilance study

  2025cites this paper
• Absence seizures and sleep–wake abnormalities in a rat model of GRIN2B neurodevelopmental disorder

  2025cites this paper
• Valproic Acid in Women of Reproductive Potential: Panacea or Pandora's Box.

  2025cites this paper
• The whole-brain dynamic neuromagnetic network characteristics in childhood absence epilepsy: A multi-frequency magnetoencephalography study.

  2025cites this paper
• Antiseizure potential of the triple T‐type calcium channel blocker ACT‐709478 (apinocaltamide) in rodent models

  2025cites this paper
• Pediatric Epilepsy Management: Special Considerations

  2025cites this paper
• Therapeutic potential of ketamine in management of epilepsy: Clinical implications and mechanistic insights.

  2024cites this paper
• Parvalbumin Interneuron Dysfunction in Neurological Disorders: Focus on Epilepsy and Alzheimer’s Disease

  2024cites this paper
• Brain Metastasis in the Emergency Department: Epidemiology, Presentation, Investigations, and Management

  2024cites this paper
• Molecular Mechanisms Underlying the Generation of Absence Seizures: Identification of Potential Targets for Therapeutic Intervention

  2024cites this paper
• Anti-seizure medication prescription preferences: a Moroccan multicenter study

  2024cites this paper
• Ethosuximide lowers lamotrigine serum concentrations: Evidence for a clinically relevant interaction

  2024cites this paper
• Ethnic Aspects of Valproic Acid P-Oxidation

  2024cites this paper
• Temporal and Potential Predictive Relationships between Sleep Spindle Density and Spike-and-Wave Discharges

  2024cites this paper
• A Comparative Study between Mono Antiepileptic Therapy and Poly Antiepileptic Therapy regarding Quality of Life in Adolescents with Epilepsy

  2024cites this paper
• Cortical Tonic Inhibition Gates the Expression of Spike-and-Wave Discharges Associated with Absence Epilepsy.

  2024cites this paper
• Unveiling the role of histone deacetylases in neurological diseases: focus on epilepsy

  2024cites this paper
• A Review of Hyperventilation Activation in Diagnosis and Management of Childhood Absence Epilepsy

  2024cites this paper
• Behavioral and Cognitive Comorbidities in Genetic Rat Models of Absence Epilepsy (Focusing on GAERS and WAG/Rij Rats)

  2024cites this paper
• Genetic and non-genetic factors influencing the therapeutic response of valproic acid in pediatric epileptic patients.

  2024cites this paper
• The landscape of drug resistant absence seizures in adolescents and adults: Pathophysiology, electroclinical spectrum and treatment options.

  2024cites this paper
• Predicting the therapeutic response to valproic acid in childhood absence epilepsy through electroencephalogram analysis using machine learning.

  2024cites this paper
• NLRP3 Inflammasome Inhibitors for Antiepileptogenic Drug Discovery and Development

  2024cites this paper
• Care of pharmaco-resistant absence seizures in childhood.

  2024cites this paper
• Epilepsy core outcome set for effectiveness trials (EPSET): A systematic review of outcomes measured in registered phase III and IV clinical trials for adults with epilepsy.

  2024cites this paper
• Growth-related effects of antiseizure medications are of concern in children with epilepsy

  2023cites this paper
• The therapeutic effects of lacosamide on epilepsy-associated comorbidities

  2023cites this paper
• Minimum effective sodium valproate dose in genetic generalized epilepsies.

  2023cites this paper
• Thalamocortical circuits in generalized epilepsy: Pathophysiologic mechanisms and therapeutic targets

  2023cites this paper
• Cognitive phenotype of juvenile absence epilepsy: An investigation of patients and unaffected siblings

  2023cites this paper
• EEG phase synchronization during absence seizures

  2023cites this paper
• Model‐Informed Precision Dosing Guidance of Ethosuximide Developed from a Randomized Controlled Clinical Trial of Childhood Absence Epilepsy

  2023cites this paper
• Idiopathic Generalized Epilepsy

  2023cites this paper
• Drug-resistant idiopathic generalized epilepsy: A meta-analysis of prevalence and risk factors.

  2023cites this paper
• A 5-Year Study of Antiseizure Medications (ASMs) Monitoring in Patients with Neuropsychiatric Disorders in an Italian Clinical Center

  2023cites this paper
• Structural insights of novel mutational frames in Bromodomain Containing-2 gene (BRD2) in juvenile myoclonic epilepsy: bed, bench, and laptop profiles.

  2023cites this paper
• Idiopathic generalized epilepsies: Which seizure type is more difficult to control?

  2023cites this paper
• School performance and psychiatric comorbidity in childhood absence epilepsy: A Danish cohort study.

  2022cites this paper
• Higher-order thalamic nuclei facilitate the generalization and maintenance of spike-and-wave discharges of absence seizures

  2022cites this paper
• Cannabinoid 1/2 Receptor Activation Induces Strain-Dependent Behavioral and Neurochemical Changes in Genetic Absence Epilepsy Rats From Strasbourg and Non-epileptic Control Rats

  2022cites this paper
• Psychobehavioural and Cognitive Adverse Events of Anti-Seizure Medications for the Treatment of Developmental and Epileptic Encephalopathies

  2022cites this paper
• Farelerde Pentilentetrazol ile Oluşturulan Akut Epileptik Nöbetler Üzerine Folik Asidin Etkisi

  2022cites this paper
• Recurrence rates and risk factors for seizure recurrence following antiseizure medication withdrawal in adolescent patients with genetic generalized epilepsy

  2022cites this paper
• Childhood vs. juvenile absence epilepsy: How to make a diagnosis.

  2022cites this paper
• A Practical Guide to the Treatment of Dravet Syndrome with Anti-Seizure Medication

  2022cites this paper
• The effect of chronic treatment with sodium channel blocker lacosamide on early development of absence seizures in genetic absence epilepsy rats.

  2022cites this paper
• EEG parameters as endpoints in epilepsy clinical trials - An expert panel opinion paper.

  2022cites this paper
• Current Concepts in the Management of Idiopathic Generalized Epilepsies

  2022cites this paper
• An innovative ethosuximide granule formulation designed for pediatric use: Comparative pharmacokinetics, safety, tolerability, and palatability profile versus reference syrup

  2022cites this paper
• Update on Antiseizure Medications 2022

  2022cites this paper
• The Effect of Valproic Acid and Furosemide on the Regulation of the Inflammasome Complex (NLRP1 and NLRP3 mRNA) in the Brain of Epileptic Animal Model.

  2022cites this paper
• The cognitive phenotype of juvenile absence epilepsy and its heritability: an investigation of patients and unaffected siblings

  2022cites this paper
• Impact of Antiseizure Medications on Appetite and Weight in Children

  2022cites this paper
• The Impact of Glutamatergic Synapse Dysfunction in the Corticothalamocortical Network on Absence Seizure Generation

  2022cites this paper
• Efficacy and tolerability of antiseizure drugs

  2021cites this paper
• Pretreatment Source Location and Functional Connectivity Network Correlated With Therapy Response in Childhood Absence Epilepsy: A Magnetoencephalography Study

  2021influential citation
• Activity of the Lateral Hypothalamus during Genetically Determined Absence Seizures

  2021cites this paper
• From Physiology to Pathology of Cortico-Thalamo-Cortical Oscillations: Astroglia as a Target for Further Research

  2021cites this paper
• Updates for Child Neurology.

  2021cites this paper
• Absence Seizure Detection Algorithm for Portable EEG Devices

  2021cites this paper
• Neuropharmacology of Antiseizure Drugs

  2021cites this paper
• Role of Common Genetic Variants for Drug-Resistance to Specific Anti-Seizure Medications

  2021cites this paper
• Pediatric adverse reactions to antiseizure medications - An analysis of data from the Italian spontaneous reporting system (2001-2019).

  2021cites this paper
• Neurocognitive Effects of Antiseizure Medications in Children and Adolescents with Epilepsy

  2021cites this paper
• Rational Antiepileptic Treatment in Childhood

  2021cites this paper
• Ethosuximide inhibits acute histamine- and chloroquine-induced scratching behavior in mice

  2021cites this paper
• Ethosuximide, sodium valproate or lamotrigine for absence seizures in children and adolescents.

  2021influential citation
• Heterogenity of childhood absence epilepsies

  2021cites this paper
• Systemic administration of ivabradine, a hyperpolarization‐activated cyclic nucleotide‐gated channel inhibitor, blocks spontaneous absence seizures

  2021cites this paper
• Contribution of rare genetic variants to drug response in absence epilepsy.

  2021cites this paper
• Interictal Activity Is Associated With Slower Binocular Rivalry in Idiopathic Generalized Epilepsy

  2021cites this paper
• Experimental Therapeutic Strategies in Epilepsies Using Anti-Seizure Medications

  2021cites this paper
• Evidence‐based anti‐seizure monotherapy in newly diagnosed epilepsy: A new approach

  2020cites this paper
• The efficacy and safety of lamotrigine for absence seizures in children and adolescents: A systematic review and meta-analysis.

  2020cites this paper
• Absence Seizures in Children: Usual and the Unusual

  2020cites this paper
• Does Early Recognition of Treatment Failure and Changing Anti-Epilepsy Medication Regimen Improve Short-Term Seizure Remission Rates In Childhood Absence Epilepsy?

  2020cites this paper
• High-power, frontal-dominant ripples in absence status epilepticus during childhood.

  2020cites this paper
• Épilepsies bénignes de l’enfant

  2020cites this paper
• 30 years of second-generation antiseizure medications: impact and future perspectives.

  2020cites this paper
• Clinical and experimental insight into pathophysiology, comorbidity and therapy of absence seizures

  2020influential citation
• Physiology-Based Treatment of Myoclonus

  2020cites this paper
• Testing association of rare genetic variants with resistance to three common antiseizure medications

  2020cites this paper
• Are the new anti-epileptic drugs any better than their predecessors ?

  2020cites this paper
• Prise en charge thérapeutique des adolescents atteints d'épilepsie généralisée idiopathique dans une cohorte Marseillaise suivie entre 2001 et 2019

  2020cites this paper
• Langezeitprognose pharmakologischer Therapien

  2020cites this paper
• Initiating antiepilepsy treatment: An update of expert consensus in Spain.

  2020cites this paper
• Diagnosing and managing childhood absence epilepsy by telemedicine.

  2020cites this paper
• Anti-convulsant Agents: Ethosuximide and Methsuximide

  2020cites this paper
• Alternatives to valproate in girls and women of childbearing potential with Idiopathic Generalized Epilepsies: state of the art and guidance for the clinician proposed by the Epilepsy and Gender Commission of the Italian League Against Epilepsy (LICE).

  2020cites this paper
• Anticonvulsant Agents: Beginning and Duration of Therapy, Withdrawal, and Resistance – Children

  2020cites this paper
• Epilepsias benignas del niño

  2020cites this paper
• An Update to Approach to the Childhood Electroclinical Syndromes

  2020cites this paper
• Epilepsy—Work-Up and Management in Children

  2020cites this paper
• Active avoidance learning in WAG/Rij rats with genetic predisposition to absence epilepsy.

  2020cites this paper
• Pharmacological Management of the Genetic Generalised Epilepsies in Adolescents and Adults

  2020cites this paper